Meta Pixel

News and Announcements

Phylogica and Pfizer Reach Project Milestone

  • Published June 07, 2012 12:09AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Phylogica Limited (ASX:PYC) CFO & VP Corporate Development, Nick Woolf, explains the significance of the peptide drug discovery company’s latest project milestone with Pfizer. The collaboration was inked in December 2010 and saw Phylogica receive an upfront payment of $US0.5 million. Reaching the most recent milestone comes after the company received an undisclosed milestone payment for successfully completing the first stage of the collaboration in December 2011.

Under the terms of the deal Phylogica will also receive a payment for reaching the latest milestone. Mr Woolf explains where Phylogica will put the funds and when it expects to reach the next milestone as part of the collaboration and license agreement to discover novel peptide-based vaccines.

——

To view the full article, please click here.

 

Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets

QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Join over 45,000+ sophisticated investors

Join Now